Arkolith/Insider Trading/MBII/Form 4

Pitts Keith

SVP & Chief Sust. OfficerMARRONE BIO INNOVATIONS INC (MBII) · full profile →Form 4 · filed Jul 14, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 12, 2022Grant(A)103K—$0221K
Jul 12, 2022Disposed to issuer(D)221K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 12, 2022Option exercise(M)103K—$00
Jul 12, 2022Disposed to issuer(D)15K——0
Jul 12, 2022Disposed to issuer(D)150K——0
Jul 12, 2022Disposed to issuer(D)200K——0
Jul 12, 2022Disposed to issuer(D)2K——0
Jul 12, 2022Disposed to issuer(D)253K——0
Jul 12, 2022Disposed to issuer(D)24K——0
Jul 12, 2022Disposed to issuer(D)60K——0
Jul 12, 2022Disposed to issuer(D)50K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-042212) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML